ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

European Commission Approves Subcutaneous Rituximab

March 28, 2014

St. Jude Begins $100 Million Expansion Program

December 4, 1987

Medicare: Clinton Budget Revives Proposal To End Physician Drug Markup

February 6, 1998

Nobel Physicist Calls For Doubling Of Science Budget

January 11, 1991

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994